+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Ipsen Group - logo

Ipsen is a global specialty-driven pharmaceutical group committed to discovering new solutions for targeted debilitating diseases. The company offers drugs in urology – oncology, endocrinology, neurology, gastroenterology, cognitive disorders, rheumatology, and cardiovascular areas. Its products include Decapeptyl, Hexvix, Somatuline, NutropinAq and Dysport. The company was founded in 1929 and is headquartered in Boulogne-Billancourt, France. Ipsen S.A. is a subsidiary of Mayroy S.A.

Global Insulinoma Treatment Market 2019-2023 - Product Thumbnail Image

Global Insulinoma Treatment Market 2019-2023

  • Report
  • December 2018
  • 114 pages
From
From
Pancreatic Endocrine Tumor - Pipeline Insight, 2020 - Product Thumbnail Image

Pancreatic Endocrine Tumor - Pipeline Insight, 2020

  • Clinical Trials
  • February 2020
  • 106 pages
From
Neuroblastoma - Pipeline Review, H2 2020 - Product Thumbnail Image

Neuroblastoma - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 1084 pages
From
Oligodendroglioma - Pipeline Review, H2 2020 - Product Thumbnail Image

Oligodendroglioma - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 175 pages
From
From
Oligodendroglioma - Pipeline Insight, 2020 - Product Thumbnail Image

Oligodendroglioma - Pipeline Insight, 2020

  • Clinical Trials
  • February 2020
  • 106 pages
From
From
Neuropathic Pain - Pipeline Review, H2 2019 - Product Thumbnail Image

Neuropathic Pain - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 838 pages
From
From
From
Renal Cell Carcinoma - Pipeline Insight, 2021 - Product Thumbnail Image

Renal Cell Carcinoma - Pipeline Insight, 2021

  • Clinical Trials
  • March 2021
  • 120 Pages
From
From
Loading Indicator
adroll